Dihexa has demonstrated remarkable results in preclinical (animal) studies, including significant improvements in synaptic density, neuronal survival, and spatial memory in rodent models of cognitive impairment
Reducing toxins
IKK activation could phosphorylate NF-B inhibitors, leading to their degradation by the proteasome, which then activates and releases NF-B complexes into the nucleus to trigger the expression of target genes involved in cell proliferation and apoptosis, initiating downstream signaling pathways [108]
Until rigorous studies show that BPC-157 does not awaken any sleeping dragons (like micrometastases), its best viewed with deep skepticism
doi:10.1016/j.jsmc.2018.04.005 Warland J, Dorrian J, Morrison JL, O'Brien LM
Glucosinolate derivatives as antifungals: A review